Symbol Lookup

Monday May 30, 2016 4:14 PM ET. Data delayed 15 minutes.
6.37
0.12 (1.92%)
Bid/Lots
6.37/5
Ask/Lots
6.38/2
Open/Prev Close
6.25/6.25
Day Range
6.14-6.40
52-Week Range
4.26-23.61
Vol/Avg Daily Vol
627.9K/482.2K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
BRIEF-Cara Therapeutics reports Q1 loss per share $0.39
4:35PM ET on Thursday May 05, 2016 by Thomson Reuters
Companies Mentioned: CARA

May 5 (Reuters) - Cara Therapeutics Inc

* Cara Therapeutics reports first quarter 2016 financial results

* Q1 loss per share $0.39

* Q1 earnings per shar...

May 5 (Reuters) - Cara Therapeutics Inc

* Cara Therapeutics reports first quarter 2016 financial results

* Q1 loss per share $0.39

* Q1 earnings per shar...

Cara Therapeutics Reports First Quarter 2016 Financial Results
4:01PM ET on Thursday May 05, 2016 by GlobeNewswire
Companies Mentioned: CARA

- Conference call today at 4:30 p.m. ET -

Cara Therapeutics, Inc. (NASDAQ:CARA), a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced financial results for the first quarter ended March 31, 2016.

- Conference call today at 4:30 p.m. ET -

Cara Therapeutics, Inc. (NASDAQ:CARA), a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectivel...

May 4, 2016

Cara Therapeutics to Sponsor Symposium at American Pain Society 35th Annual Scientific Meeting
8:00AM ET on Wednesday May 04, 2016 by GlobeNewswire
Companies Mentioned: CARA

-- Pain experts to discuss kappa opioid receptor agonists as alternative to standard mu opioid agonists

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, today announced that it is sponsoring a Town Hall Talk titled "Moving Beyond Mu with Kappa Opioid Receptor Agonists: Leaving the Baggage Behind" in two sessions at the American Pain Society's 35 Annual Scientific Meeting, to be held May 11-14, 2016 in Austin, Texas.

-- Pain experts to discuss kappa opioid receptor agonists as alternative to standard mu opioid agonists

Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities design...

Peers Headlines

May 27, 2016

ProNAi Therapeutics Shares Rise 6%; Licenses Cancer Drug Candidate From Carna Biosciences
7:48AM ET on Friday May 27, 2016 by MT Newswires
Companies Mentioned: DNAI
07:48 AM EDT, 05/27/2016 (MT Newswires) -- ProNAi Therapeutics (DNAI) shares were higher over 6% in recent pre-market trade after the company said it has obtained an exclusive license from Japan's Carna Biosciences for worldwide rights to develop...

May 26, 2016

BRIEF-Pronai licenses cancer drug candidate from Carna Biosciences
7:40PM ET on Thursday May 26, 2016 by Thomson Reuters
Companies Mentioned: DNAI

May 26 (Reuters) - Pronai Therapeutics Inc

* Pronai licenses cancer drug candidate targeting CDC7 from Carna Biosciences

* Qtrly has obtained an exclusi...

European ADRs Fractionally Higher as Miners Post Gains
10:56AM ET on Thursday May 26, 2016 by MT Newswires
Companies Mentioned: UL, AMRN, GWPH, BBL, CUK, SAN, RBS, NBRV, AAAP
10:56 AM EDT, 05/26/2016 (MT Newswires) -- American depository receipts of European stocks were 0.1% higher at 124.29 on the Bank of New York Mellon Europe ADR Index on Thursday morning. Gainers in Continental Europe were led by ArcelorMittal (M...
Akari Therapeutics to Present at the Jefferies 2016 Healthcare Conference
7:00AM ET on Thursday May 26, 2016 by GlobeNewswire
Companies Mentioned: AKTX

Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, today announced that Gur Roshwalb, MD, Chief Executive Officer, will present and participate in a question-and-answer session at the Jefferies 2016 ...

May 25, 2016

European ADRs Advance as Spanish Banks Rally
11:20AM ET on Wednesday May 25, 2016 by MT Newswires
Companies Mentioned: BBVA, TI.A, SQNS, AKTX, GWPH, CGG, CUK, FLY, SAN, RBS, NBRV
11:20 AM EDT, 05/25/2016 (MT Newswires) -- American depository receipts of European stocks were 1.7% higher at 124.15 on the Bank of New York Mellon Europe ADR Index on Wednesday morning. Gainers in Continental Europe were led by Spanish banks Ba...
European ADRs Advance as Spanish Banks Rally
11:20AM ET on Wednesday May 25, 2016 by MT Newswires
Companies Mentioned: BBVA, TI.A, SQNS, AKTX, GWPH, CGG, CUK, FLY, SAN, RBS, NBRV
11:20 AM EDT, 05/25/2016 (MT Newswires) -- American depository receipts of European stocks were 1.7% higher at 124.15 on the Bank of New York Mellon Europe ADR Index on Wednesday morning. Gainers in Continental Europe were led by Spanish banks Ba...

May 23, 2016

BRIEF-Akari Therapeutics gets positive opinion for Coversin's orphan drug designation in EU
7:30AM ET on Monday May 23, 2016 by Thomson Reuters
Companies Mentioned: AKTX

May 23 (Reuters) - Akari Therapeutics Plc :

* Akari therapeutics receives positive opinion for orphan drug designation for Coversin in the European Uni...

Akari Therapeutics Receives Positive Opinion On Orphan Drug Designation For Guillain Barre Drug In Europe
7:20AM ET on Monday May 23, 2016 by MT Newswires
Companies Mentioned: AKTX
07:20 AM EDT, 05/23/2016 (MT Newswires) -- Akari Therapeutics (AKTX), a biopharmaceutical company, said the European Medicines Agency has issued a positive opinion recommending orphan drug designation for Coversin in the treatment of Guillain Bar...
Akari Therapeutics Receives Positive Opinion for Orphan Drug Designation for Coversin in the European Union for Treatment of Guillain Barre Syndrome
7:10AM ET on Monday May 23, 2016 by GlobeNewswire
Companies Mentioned: AKTX

Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion recommending o...

May 20, 2016

ADR Top % Movers in Pre-Market Trading
8:51AM ET on Friday May 20, 2016 by MT Newswires
Companies Mentioned: GGB, AIXG, GRVY, SID, SFUN, RENN, NQ, HIMX, AKTX, MZOR, HQCL, CMCM, JMEI, CIG
08:51 AM EDT, 05/20/2016 (MT Newswires) -- ADR Top % Movers in Pre-Market Trading Gainers SHPG +3.0% CS +2.6% GOLD +1.1% BBL +0.8% BHP +0.8% AZN +0.5% GSK +0.4% NOK +0.3% VOD +0.3% AU +0.1% Losers No decliners at the time of writing. Price: 16.36...
← Newer123Older →